IRIS
PREZIOSO, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.910
NA - Nord America 3.879
EU - Europa 2.650
SA - Sud America 565
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 117
OC - Oceania 8
Totale 12.253
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.721
SG - Singapore 2.312
RU - Federazione Russa 1.376
VN - Vietnam 966
CN - Cina 782
BR - Brasile 468
HK - Hong Kong 414
IT - Italia 386
FR - Francia 233
FI - Finlandia 174
UA - Ucraina 124
DE - Germania 114
IN - India 88
CA - Canada 79
GB - Regno Unito 72
JP - Giappone 39
BD - Bangladesh 38
MX - Messico 38
NL - Olanda 37
CI - Costa d'Avorio 36
IQ - Iraq 35
TH - Thailandia 32
AR - Argentina 31
PH - Filippine 28
IE - Irlanda 27
ZA - Sudafrica 27
KR - Corea 25
PL - Polonia 25
ID - Indonesia 20
SE - Svezia 20
EC - Ecuador 19
TR - Turchia 18
TW - Taiwan 17
UZ - Uzbekistan 14
ES - Italia 12
PK - Pakistan 12
JM - Giamaica 11
KE - Kenya 10
PY - Paraguay 10
VE - Venezuela 10
AT - Austria 9
EG - Egitto 8
LT - Lituania 8
MA - Marocco 8
CO - Colombia 7
SA - Arabia Saudita 7
UY - Uruguay 7
AM - Armenia 6
DZ - Algeria 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CL - Cile 5
HN - Honduras 5
LB - Libano 5
PE - Perù 5
TN - Tunisia 5
BB - Barbados 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
EU - Europa 4
GT - Guatemala 4
IR - Iran 4
KG - Kirghizistan 4
AL - Albania 3
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
MK - Macedonia 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
CW - ???statistics.table.value.countryCode.CW??? 2
FJ - Figi 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
YE - Yemen 2
AD - Andorra 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
Totale 12.109
Salva come PNG Salva come JPEG
Città #
Singapore 998
San Jose 676
Hong Kong 400
Moscow 369
Ho Chi Minh City 289
Santa Clara 251
Hanoi 234
Ashburn 208
Beijing 168
The Dalles 161
Princeton 148
Boston 144
Lauterbourg 141
Millbury 126
Nanjing 113
Jacksonville 107
Los Angeles 87
Chandler 80
Redondo Beach 70
Buffalo 63
Council Bluffs 54
Des Moines 54
Hefei 54
Naples 48
New York 46
Da Nang 43
Haiphong 42
Nanchang 41
São Paulo 41
Wilmington 40
Munich 38
Ottawa 37
Tokyo 30
Dallas 29
Napoli 27
Jiaxing 24
Rome 23
Seattle 23
Warsaw 23
Brooklyn 22
Milan 22
Hebei 21
Amsterdam 20
Orem 20
Shenyang 20
Atlanta 19
Mexico City 19
Tianjin 19
Denver 18
Rio de Janeiro 18
Turku 18
Norwalk 16
Nuremberg 16
Chennai 15
Houston 15
Changsha 14
San Francisco 14
Tashkent 14
Belo Horizonte 13
Chicago 13
Dublin 13
Hải Dương 13
Memphis 13
Montreal 13
Phoenix 12
Seoul 12
Biên Hòa 11
Can Tho 11
Frankfurt am Main 11
Lawrence 11
Bangkok 10
Cimitile 10
Falls Church 10
Poplar 10
Baghdad 9
Mumbai 9
Nairobi 9
Porto Alegre 9
Querétaro 9
Hangzhou 8
Johannesburg 8
London 8
Stockholm 8
Ankara 7
Asunción 7
Bengaluru 7
Brasília 7
Bến Tre 7
Curitiba 7
Dhaka 7
Genova 7
Manchester 7
Manila 7
Montevideo 7
New Delhi 7
Quito 7
Salvador 7
Thái Bình 7
Toronto 7
Bình Phước 6
Totale 6.271
Salva come PNG Salva come JPEG
Nome #
Adherence to Mediterranean Diet, Dietary Salt Intake, and Susceptibility to Nephrolithiasis: A Case-Control Study 288
Metabolic syndrome is associated to an increased risk of low bone mineral density in free-living women with suspected osteoporosis 147
Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer 144
Renal metastasis from thyroid carcinoma 35 years after detection of the primary tumor 143
Retrograde intra renal surgery versus percutaneous nephrolithotomy for renal stones >2 cm. A systematic review and meta-analysis 135
Correlation between ion composition of oligomineral water and calcium oxalate crystal formation 133
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group 132
The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. 130
Monolateral recurrent soft urolithiasis: Case report and stone analysis 130
Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients 128
Tissue-resonance interaction method for the noninvasive diagnosis of prostate cancer: analysis of a multicentre clinical evaluation. 126
Osteoporosis is a Predictive Factor for Nephrolithiasis in an Adult Free-Living Caucasian Population From Southern Italy: A Longitudinal Retrospective Study Based on a General Practice Database 125
Preoperative monocyte-to-lymphocyte ratio as a potential predictor of bladder cancer 121
Neoadjuvant hormone treatment with leuprolide acetate depot 3.75 mg and cyproterone acetate, before radical prostatectomy: a randomized study. 118
Ureteral access sheaths in RIRS: a retrospective, comparative, single-center study 117
. Sexual Asthenia: Tradamixina Versus Tadalafil 5 Mg Daily 117
Lower urinary tract symptoms and mental health during COVID-19 pandemic 116
Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction 115
Mannose-binding lectin genetic analysis: possible protective role of the HYPA haplotype in the development of recurrent urinary tract infections in men 113
Italian validation of the International Consultation on Incontinence Questionnaires. 112
Metabolic syndrome is not associated to an increased risk of low bone mineral density in men at risk for osteoporosis 112
The role of the general practictioner in the management of urinary calculi 110
The clinical implications of the prostate cancer prevention trial 109
Risk Factors for Testicular Cancer: Environment, Genes and Infections-Is It All? 107
Cavernous body reduction in four patients with erectile dysfunction due to insufficient venous occlusion and a deficit of elastic fibers in the Tunica Albuginea 106
Observational study: daily treatment with a new compound “tradamixina” plus serenoa repens for two months improved the lower urinary tract symptoms. 105
LASMATIC SIL 6R/IL-6 RATIO AS A POTENTIAL PREDICTOR OF HIGH GLEASON SUM AT RADICAL PROSTATECTOMY. In: ANTICANCER RESEARCH 102
In-vitro and in-vivo new evidence for Flexor® Vue™ deflecting endoscopic system use: optimization of the stone free rate (SFR) after flexible ureteroscopy and Ho:YAG laser lithotripsy 101
Sexual asthenia: Tradamixina versus Tadalafil5 mg daily 99
Stone residual fragments: A thorny problem 99
Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients. 98
Chronic pain in urological diseases: a clinical review 98
Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients. 97
Early versus delayed hormonal treatment in locally advanced or asymptomatic metastatic prostatic cancer patient dilemma. 97
Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and ED. 96
Efficacy and safety profile of a novel technique,ThuLEP (Thulium laser enucleation of theprostate) for the treatment of benign prostatehypertrophy. Our experience on 148 patients 96
Erratum: Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group (Archivio Italiano di Urologia e Andrologia (2016) 88:1 DOI:10.4081/aiua.2015.2.105) 96
Testosterone deficiency causes penile fibrosis andorganic erectile dysfunction in aging men.Evaluating association among Age, TDS and ED 95
Quality of life evaluation by the EORTC QLQ-C30 questionnaire in patients treated with hormonal treatment in Italy. A QuABIOS group study 93
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas 93
Tunical plication in the management of penile curvature due La Peyronie’s disease. Our experience on 47 cases. 93
Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study. 92
The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy 92
Comparative Study between Levobupivacaine and Bupivacaine for Hernia Surgery in the Elderly. 91
Observational Database Serenoa Repens (DOSSER): Overview, analysis and results 90
Italian validation of the urogenital distress inventory and its application in LUTS patients. 86
Introduction to chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS). 84
Economic evaluation of different hormonal therapies for prostate cancer. Final results from the Quality of Life Antiandrogen Blockade Italian Observational Study (QuABIOS). 83
Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement. 83
Treatment of Erectile Dysfunction with a New Natural Drug Composition Based on Tribulus Terrestris, Biovis and Alga Ecklonia in 83 patients. SIU World Meeting Lower Urinary Tract Dysfunction 83
Stress urinary incontinence: long-term results of laparoscopic Burch colposuspension 83
Estrogens and aspects of prostate disease. 81
Analyzing the efficacy of a new natural compound made of the alga Ecklonia bicyclis, Tribulus terrestris and BIOVIS® in order to improve male sexual function 81
Estrogen receptor B expression in human prostate tissue 81
Presenting a case of a mucinous adenocarcinoma of an exstrophic bladder in an adult patient and a review of literature 81
The role of somatostatin analogs in the management of prostate cancer 79
Estrogens and prostatic disease 79
Adenoma nefrogenico a localizzazione rara:uretra. Presentazione di un caso e review della letteratura 79
Role of surgery in treatment of locally advanced prostate cancer. 78
Quality of life and distress in Italian women with LUTS: The results of a one -year follow-up from the FLOW Study 75
Remarkable simplification of intracoroporal poharmacotherapy by means of an autonomic autoiniector 74
Prostate cancer treatment and quality of life. 73
New diagnostic prospects with serum markers in cancer of the prostate 73
Observational study: daily treatment with a newcompound “tradamixina” plus serenoa repens fortwo months improved the lower urinary tractsymptoms 73
Hormonal treatment for prostate cancer in Italy. Preliminary data from a survey of the QUABIOS Group 72
the influence of long term treatment with mepartricin in a single daily dose on the symptomatology of begnign prostate hypertrophy 72
Saponins, Phlorotannins and Glycosamine contained in Tribulus Terrestris, Biovis and Alga Ecklonia Cava in the treatment of Erectile Dysfunction : A Preliminary Study. 72
Laboratory assessment. 70
The prevention of prostate cancer. 70
Antibacterial prophylaxis in endourological procedures 70
A case of giant cell tumor of the hipbone invading the bladder 70
Changing concepts on prostatitis 70
Incidence and remission rates of LUTS associated with sexual intercouse and their impact on the quality of life 69
changes in tissue transglutaminase activity and expression during retinoic acid induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells 69
The international terazosin trial:a multicentre study of the long term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia 69
Angiomyolipoma associated with renal carcinoma.Case report 69
ASSOCIAZIONI TERAPEUTICHE IN FARMACOPROTESI: FENTOLAMINE E KETANSERINA A CONFRONTO | [Combinations in intracorporeal pharmacotherapy: Comparison between phentolamine and ketanserin] 69
Pilot clinical study on the use of active drugs in the treatment of benign prostatic hyperplsia.Controlled study 68
cavernous body reduction in four patients with erectile dysfuction due to insufficient venous occlusion and a deficit of elastic fibers in the Tunica Albuginea 67
Le stenosi della via escretrice superiore ed il loro trattamento endourologico: nostra casistica e revisione della letteratura. 67
Role of neoadjuvant treatment in clinically confined prostate cancer 66
The nocturnal penile tumescence test in patients with priapism treated by cyproterone acetate 66
Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer. 65
Infections and urolithiasis: current clinical evidence in prophylaxis and antibiotic therapy 65
Espressione dei recettori orfani LXR(liver x receptors) a e b nelle cellule epiteliali prostatiche umane 65
Luts oggi, quali soluzioni 64
Espressione della EG-VEGF e della prosteina procinetina 1 nelle cellule di prostata umana normali e tumoral. 64
Prostate cancer (PCA) prevalence and risk factors in men low urinary tract symptoms (LUTS) in Italy:Preliminary report of an observational multicenter study 64
Evolution and management of LUTS in women after a 2 year follow-up:FLOW study 63
leuprolin 1 month depot as neoadjuvant therapy for prostate cancer 63
New prospective diagnostic serum markers in prostatic cancer 63
Economic evaluation of different hormonal therapies for prostate cancer. Final results from the Quality of Life Antiandrogen Blockade Italian Observational Study (QuABIOS) 63
tHerapeutic usefulness of mepartricin in benign prostatic hypertrophy:2 years' experience .Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy 62
somatostatin receptor binding domain expression is up-regulated by estradiol in prostate cells 61
antiproliferative effects of LXR alpha and LXR beta activation by synthetic oxysterol on prostate cells in vitro 61
Terapia delle prostatiti croniche Abatteriche tramite tecnica EMDA 61
OPERA: studio osservazionale sul cancro della prostata. Epidemiologia e fattori di rischio 61
LUTS evolution in a simple of italian women presenting at urology centres.The Flow Study 60
THULEP ED ATV PER IL TRATTAMENTO DI VOLUMINOSI ADENOMI PROSTATICI: DUE METODICHE A CONFRONTO. 5 ANNI DI ESPERIENZA 60
La melatonina agisce attraverso il recettore Mel 1° sulle cellule epiteliali di prostata normali e cancerose in coltura cellulare 60
Totale 9.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022584 0 3 5 4 7 8 10 25 28 52 73 369
2022/2023358 161 3 2 15 24 32 0 25 45 19 26 6
2023/2024380 8 58 42 30 8 8 11 39 3 3 120 50
2024/20253.529 230 329 12 13 114 146 379 172 376 352 1.059 347
2025/20265.966 679 429 542 494 977 229 625 425 985 383 104 94
2026/2027318 165 153 0 0 0 0 0 0 0 0 0 0
Totale 12.253